Autolus Therapeutics plc Annual Nonoperating Income (Expense) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Autolus Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2023.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $708K.
  • Autolus Therapeutics plc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$40.1M, a 1230% decline year-over-year.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2023 was -$28.7M, a 456% decline from 2022.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$5.16M, a 422% decline from 2021.
  • Autolus Therapeutics plc annual Nonoperating Income (Expense) for 2021 was -$988K, a 152% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$28.7M -$23.5M -456% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$5.16M -$4.17M -422% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$988K -$2.88M -152% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $1.89M -$5.17M -73.2% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 $7.06M +$1.55M +28.2% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-10
2018 $5.5M +$5.46M +14379% Oct 1, 2017 Sep 30, 2018 20-F 2020-03-03
2017 $38K -$11K -22.4% Oct 1, 2016 Sep 30, 2017 20-F 2020-03-03
2016 $49K Oct 1, 2015 Sep 30, 2016 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.